Cara Therapeutics Appoints Ryan Maynard as Chief Financial Officer
Go back to Cara Therapeutics Appoints Ryan Maynard as Chief Financial Officer| CARA THERAPEUTICS (NASDAQ: CARA) | Delayed: 5.32 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.32 | 52 Week High | $17.69 | |||
| Open | $5.32 | 52 Week Low | $4.26 | |||
| Day High | $5.32 | P/E | N/A | |||
| Day Low | $5.32 | EPS | $-0.42 | |||
| Volume | 246,608 | |||||
| (NASDAQ: IOVA) | Delayed: 6.52 -0.22 (3.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.74 | 52 Week High | $ | |||
| Open | $6.74 | 52 Week Low | $ | |||
| Day High | $6.81 | P/E | N/A | |||
| Day Low | $6.51 | EPS | $ | |||
| Volume | 5,106,016 | |||||
| Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) | Delayed: 40.72 -1.15 (2.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $41.87 | 52 Week High | $4.38 | |||
| Open | $42.59 | 52 Week Low | $1.88 | |||
| Day High | $42.60 | P/E | N/A | |||
| Day Low | $40.71 | EPS | $-1.12 | |||
| Volume | 51,855 | |||||
